ASX - By Stock
|
IMC |
Re:
Banter and General Comments
|
|
ich
|
24 |
7.5K |
0 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
24
|
7.5K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Banter and General Comments
|
|
ich
|
24 |
7.5K |
4 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
24
|
7.5K
|
4
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Immuron Travelan sales continued strong growth
|
|
ich
|
11 |
2.8K |
8 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
11
|
2.8K
|
8
|
|
ASX - By Stock
|
SYR |
Re:
Ann: Syrah natural graphite sales and market update
|
|
ich
|
24 |
11K |
7 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
24
|
11K
|
7
|
|
ASX - By Stock
|
SYR |
Re:
Ann: Syrah natural graphite sales and market update
|
|
ich
|
24 |
11K |
14 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
24
|
11K
|
14
|
|
ASX - By Stock
|
IMC |
Re:
Banter and General Comments
|
|
ich
|
24 |
7.5K |
0 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
24
|
7.5K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Banter and General Comments
|
|
ich
|
24 |
7.5K |
0 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
24
|
7.5K
|
0
|
|
ASX - By Stock
|
SYR Graphite |
Re:
General Discussion
|
|
ich
|
1.1K |
421K |
1 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
1.1K
|
421K
|
1
|
|
ASX - By Stock
|
IMC |
Re:
Banter and General Comments
|
|
ich
|
24 |
7.5K |
7 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
24
|
7.5K
|
7
|
|
ASX - By Stock
|
IMC |
Re:
Banter and General Comments
|
|
ich
|
24 |
7.5K |
5 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
24
|
7.5K
|
5
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Change in substantial holding
|
|
ich
|
3 |
1.1K |
0 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
3
|
1.1K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Change of Director's Interest Notice (DP)
|
|
ich
|
21 |
4.8K |
2 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
21
|
4.8K
|
2
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Travelan to progress to Phase 3 Clinical Trials in the US
|
|
ich
|
164 |
45K |
6 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
164
|
45K
|
6
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Travelan to progress to Phase 3 Clinical Trials in the US
|
|
ich
|
164 |
45K |
1 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
164
|
45K
|
1
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Travelan to progress to Phase 3 Clinical Trials in the US
|
|
ich
|
164 |
45K |
0 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
164
|
45K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Travelan to progress to Phase 3 Clinical Trials in the US
|
|
ich
|
164 |
45K |
0 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
164
|
45K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Travelan to progress to Phase 3 Clinical Trials in the US
|
|
ich
|
164 |
45K |
2 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
164
|
45K
|
2
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Travelan to progress to Phase 3 Clinical Trials in the US
|
|
ich
|
164 |
45K |
6 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
164
|
45K
|
6
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Travelan to progress to Phase 3 Clinical Trials in the US
|
|
ich
|
164 |
45K |
3 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
164
|
45K
|
3
|
|
ASX - By Stock
|
IMC |
Re:
News: IMC Immuron Seeks Trading Halt Pending Announcement On Phase 2 Imm-124E Clinical Trial...
|
|
ich
|
27 |
6.0K |
0 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
27
|
6.0K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Trading Halt
|
|
ich
|
28 |
7.3K |
0 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
28
|
7.3K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Travelan to progress to Phase 3 Clinical Trials in the US
|
|
ich
|
164 |
45K |
2 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
164
|
45K
|
2
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Travelan to progress to Phase 3 Clinical Trials in the US
|
|
ich
|
164 |
45K |
4 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
164
|
45K
|
4
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Travelan to progress to Phase 3 Clinical Trials in the US
|
|
ich
|
164 |
45K |
1 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
164
|
45K
|
1
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Travelan to progress to Phase 3 Clinical Trials in the US
|
|
ich
|
164 |
45K |
6 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
164
|
45K
|
6
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Travelan to progress to Phase 3 Clinical Trials in the US
|
|
ich
|
164 |
45K |
4 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
164
|
45K
|
4
|
|
ASX - By Stock
|
IMC |
Re:
News: IMC Immuron Seeks Trading Halt Pending Announcement On Phase 2 Imm-124E Clinical Trial...
|
|
ich
|
27 |
6.0K |
0 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
27
|
6.0K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Travelan to progress to Phase 3 Clinical Trials in the US
|
|
ich
|
164 |
45K |
3 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
164
|
45K
|
3
|
|
ASX - By Stock
|
IMC |
Re:
News: IMC Immuron Seeks Trading Halt Pending Announcement On Phase 2 Imm-124E Clinical Trial...
|
|
ich
|
27 |
6.0K |
0 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
27
|
6.0K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
News: IMC Immuron Seeks Trading Halt Pending Announcement On Phase 2 Imm-124E Clinical Trial...
|
|
ich
|
27 |
6.0K |
0 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
27
|
6.0K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
News: IMC Immuron Seeks Trading Halt Pending Announcement On Phase 2 Imm-124E Clinical Trial...
|
|
ich
|
27 |
6.0K |
0 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
27
|
6.0K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
News: IMC Immuron Seeks Trading Halt Pending Announcement On Phase 2 Imm-124E Clinical Trial...
|
|
ich
|
27 |
6.0K |
1 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
27
|
6.0K
|
1
|
|
ASX - By Stock
|
IMC |
Re:
News: IMC Immuron Seeks Trading Halt Pending Announcement On Phase 2 Imm-124E Clinical Trial...
|
|
ich
|
27 |
6.0K |
1 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
27
|
6.0K
|
1
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Appendix 4D and Half Year Report
|
|
ich
|
12 |
3.1K |
1 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
12
|
3.1K
|
1
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Appendix 4D and Half Year Report
|
|
ich
|
12 |
3.1K |
1 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
12
|
3.1K
|
1
|
|
ASX - By Stock
|
SYR |
Re:
Media Reports
|
|
ich
|
3.5K |
1.3M |
2 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
3.5K
|
1.3M
|
2
|
|
ASX - By Stock
|
IMC |
Re:
Under the radar
|
|
ich
|
37 |
9.7K |
3 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
37
|
9.7K
|
3
|
|
ASX - By Stock
|
IMC |
Re:
Under the radar
|
|
ich
|
37 |
9.7K |
1 |
22/01/24 |
22/01/24 |
ASX - By Stock
|
37
|
9.7K
|
1
|
|
ASX - By Stock
|
IMC |
Re:
Under the radar
|
|
ich
|
37 |
9.7K |
4 |
16/01/24 |
16/01/24 |
ASX - By Stock
|
37
|
9.7K
|
4
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Immuron achieves record half yearly Travelan sales
|
|
ich
|
4 |
1.3K |
0 |
16/01/24 |
16/01/24 |
ASX - By Stock
|
4
|
1.3K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Under the radar
|
|
ich
|
37 |
9.7K |
0 |
16/01/24 |
16/01/24 |
ASX - By Stock
|
37
|
9.7K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Under the radar
|
|
ich
|
37 |
9.7K |
0 |
12/01/24 |
12/01/24 |
ASX - By Stock
|
37
|
9.7K
|
0
|
|
ASX - By Stock
|
SYR |
Re:
Ann: Vidalia start of AAM production update
|
|
ich
|
29 |
15K |
14 |
12/01/24 |
12/01/24 |
ASX - By Stock
|
29
|
15K
|
14
|
|
ASX - By Stock
|
BRN |
Re:
2023 BrainChip Discussion
|
|
ich
|
6.4K |
2.3M |
6 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
6.4K
|
2.3M
|
6
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Immuron CEO, Steven Lydeamore to present at AusBioInvest
|
|
ich
|
9 |
2.3K |
2 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
9
|
2.3K
|
2
|
|
ASX - By Stock
|
SYR Graphite |
Re:
General Discussion
|
|
ich
|
1.1K |
421K |
5 |
25/10/23 |
25/10/23 |
ASX - By Stock
|
1.1K
|
421K
|
5
|
|
ASX - By Stock
|
SYR |
Re:
Great Short Opportunity
|
|
ich
|
259 |
86K |
1 |
25/10/23 |
25/10/23 |
ASX - By Stock
|
259
|
86K
|
1
|
|
ASX - By Stock
|
SYR |
Re:
Media Reports
|
|
ich
|
3.5K |
1.3M |
3 |
25/10/23 |
25/10/23 |
ASX - By Stock
|
3.5K
|
1.3M
|
3
|
|
ASX - By Stock
|
BRN |
Re:
Ann: Appendix 4C and Quarterly Activities Report
|
|
ich
|
82 |
27K |
8 |
24/10/23 |
24/10/23 |
ASX - By Stock
|
82
|
27K
|
8
|
|
ASX - By Stock
|
SYR |
Re:
Great Short Opportunity
|
|
ich
|
259 |
86K |
6 |
24/10/23 |
24/10/23 |
ASX - By Stock
|
259
|
86K
|
6
|
|